Hormone Replacement Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hormone Replacement Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type Estrogen Hormone Growth Hormone Thyroid Hormone Testosterone Hormone The proportion of estrogen hormone in 2018 is about 50%, and the proportion is in increasing trend from 2014 to 2018. Segment by Application Menopause Hypothyroidism Growth Hormone Deficiency Male Hypogonadism Other Diseases The most proportion of hormone replacement therapy is used in menopause, and the proportion in 2018 is 46.2%. By Company Eli Lilly Pfizer AbbVie Novo Nordisk Merck KGaA Mylan Bayer Teva Novartis Abbott Roche Endo International Ipsen ANI Pharmaceuticals TherapeuticsMD By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia
1 Study Coverage 1.1 Hormone Replacement Therapy Product Introduction 1.2 Market by Type 1.2.1 Global Hormone Replacement Therapy Market Size Growth Rate by Type 1.4.2 Estrogen Hormone 1.4.3 Growth Hormone 1.2.4 Thyroid Hormone 1.2.5 Testosterone Hormone 1.3 Market by Application 1.3.1 Global Hormone Replacement Therapy Market Size Growth
